4 Jun 2020 14:20
4 June 2020
Amryt Pharma plc
("Amryt" or the "Company")
Director/PDMR shareholding
This announcement, including the details included in the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Ray Stafford | |||
2. | Reason for the notification | ||||
a) | Position / status | Non-executive Chairman | |||
b) | Initial notification / amendment | Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Amryt Pharma plc | |||
b) | Legal entity identifier | 213800YNUJEOJ84L4T95 | |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.06 each
| |||
Identification code | ISIN: GB00BKLTQ412 | ||||
b) | Nature of the transaction | Purchase of ordinary shares | |||
d) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
140p | 12,500 | ||||
e) | Aggregated information - Aggregated volume
- Aggregated price
- Aggregated total |
12,500
140p
£17,500
| |||
f) | Date of the transaction | 3 June 2020 | |||
g) | Place of the transaction | London Stock Exchange (AIM) | |||
Enquiries:
Amryt Pharma plc | +353 (1) 518 0200 |
Joe Wiley, CEO Rory Nealon, CFO/COO |